Sunday, February 26, 2006


Hepatitis C - People With Chronic Hepatitis B To Benefit From Guidance On New Drugs


People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is

Tainted-blood trial will go ahead: Crown
CBC News - A Crown prosecution team says it has enough evidence to press ahead with the tainted-blood trial of the former head of the Canadian Red Cross and other health officials. Dr. Roger Perrault enters court in Toronto, Tuesday. "It is the intention of the

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial
Medical News Today - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Crown to press ahead
Regina Leader-Post - TORONTO -- The criminal case against a former director of the Canadian Red Cross arising out of the tainted blood scandal will go ahead. The Crown announced today it would proceed even though a key prosecution expert cast doubt on whether a